GH Research PLC
GHRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001855129
No open-market purchases or sales by GH Research PLC insiders were filed in the last 90 days; 63 institutions reported holding it in 13F filings for Q2 2026, worth $1.38B in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in GH Research PLC as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- 0 vs. Q3 2021
- Shares held
- 30.0M
- +1.54M (+5.4%) vs. Q3 2021
- Total value
- $701.0M
- +$75.8M (+12.1%) vs. Q3 2021
- New holders
- 8
- 8 more added
- Sold out
- 8
- 9 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GHRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 63 | $1.38B |
| Q1 2026 | 54 | $668.5M |
| Q4 2025 | 53 | $591.4M |
| Q3 2025 | 47 | $618.1M |
| Q2 2025 | 38 | $530.9M |
| Q1 2025 | 36 | $470.1M |
| Q4 2024 | 31 | $214.9M |
| Q3 2024 | 28 | $204.2M |
| Q2 2024 | 28 | $354.8M |
| Q1 2024 | 32 | $315.5M |
| Q4 2023 | 35 | $171.7M |
| Q3 2023 | 29 | $291.5M |
| Q2 2023 | 34 | $351.6M |
| Q1 2023 | 29 | $237.2M |
| Q4 2022 | 32 | $299.5M |
| Q3 2022 | 34 | $367.2M |
| Q2 2022 | 35 | $325.0M |
| Q1 2022 | 33 | $587.1M |
| Q4 2021 | 30 | $701.0M |
| Q3 2021 | 30 | $625.2M |
| Q2 2021 | 34 | $593.7M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding GH Research PLC; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 20 | $0 | 0.00% | −2−9.1% | Reduced |
| Global Retirement Partners, LLC | 220 | $5.00K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 300 | $7.00K | 0.00% | +300 | New |
| BlackRock Inc. | 4,835 | $113.0K | 0.00% | +4,835 | New |
| Virtus ETF Advisers LLC | 7,086 | $165.0K | 0.06% | +7,086 | New |
| AdvisorShares Investments LLC | 14,242 | $332.0K | 0.04% | +10,474+278.0% | Added |
| HighVista Strategies LLC | 27,010 | $630.0K | 0.50% | +27,010 | New |
| Millennium Management LLC | 27,144 | $633.0K | 0.00% | +27,144 | New |
| Penserra Capital Management LLC | 31,332 | $730.0K | 0.02% | +5,966+23.5% | Added |
| Geode Capital Management, LLC | 44,633 | $1.04M | 0.00% | +17,435+64.1% | Added |
| Ghost Tree Capital, LLC | 100,000 | $2.33M | 0.89% | −300,000−75.0% | Reduced |
| Mirae Asset Global Investments Co., Ltd. | 135,800 | $3.17M | 0.01% | +135,800 | New |
| Adage Capital Partners GP, L.L.C. | 150,000 | $3.50M | 0.01% | −250,000−62.5% | Reduced |
| Pura Vida Investments, LLC | 227,427 | $5.31M | 0.55% | −152,618−40.2% | Reduced |
| Point72 Asset Management, L.P. | 311,000 | $7.26M | 0.03% | +311,000 | New |
| Laurion Capital Management LP | 334,592 | $7.81M | 0.13% | −10,408−3.0% | Reduced |
| Acuta Capital Partners, LLC | 419,632 | $9.79M | 4.12% | +26,382+6.7% | Added |
| Morgan Stanley | 444,461 | $10.4M | 0.00% | +20,201+4.8% | Added |
| TimesSquare Capital Management, LLC | 498,299 | $11.6M | 0.10% | −2,300−0.5% | Reduced |
| Deep Track Capital, LP | 499,400 | $11.7M | 0.86% | +499,400 | New |
| Cormorant Asset Management, LP | 608,123 | $14.2M | 0.84% | 00.0% | Unchanged |
| Boxer Capital, LLC | 1,013,399 | $23.6M | 0.94% | 00.0% | Unchanged |
| Verition Fund Management LLC | 1,043,099 | $24.3M | 0.31% | −220,025−17.4% | Reduced |
| Citadel Advisors LLC | 1,275,732 | $29.8M | 0.03% | −36,914−2.8% | Reduced |
| OrbiMed Advisors LLC | 1,428,732 | $33.3M | 0.43% | +660.0% | Added |
| VR Adviser, LLC | 2,021,985 | $47.2M | 6.45% | +379,689+23.1% | Added |
| RTW Investments, LP | 2,168,957 | $50.6M | 0.74% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 2,843,757 | $66.3M | 1.17% | −170,200−5.6% | Reduced |
| FMR LLC | 5,090,566 | $118.8M | 0.01% | +2,806,602+122.9% | Added |
| BVF Inc | 9,275,158 | $216.4M | 7.85% | 00.0% | Unchanged |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −560,000−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −405,416−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −324,333−100.0% | Sold out |
| HealthCor Management, L.P. | 0 | $0 | 0.00% | −164,912−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −48,866−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −40,748−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −38,408−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −17,223−100.0% | Sold out |